CO4520276A1 - NEW THERAPEUTIC ANTI-INFLAMMATORY AND ANALGESICAL COMPOSITION CONTAINING NIMESULIDE, FOR TRANSDERMIC USE AND PROCEDURE OF THE SAME - Google Patents
NEW THERAPEUTIC ANTI-INFLAMMATORY AND ANALGESICAL COMPOSITION CONTAINING NIMESULIDE, FOR TRANSDERMIC USE AND PROCEDURE OF THE SAMEInfo
- Publication number
- CO4520276A1 CO4520276A1 CO96029489A CO96029489A CO4520276A1 CO 4520276 A1 CO4520276 A1 CO 4520276A1 CO 96029489 A CO96029489 A CO 96029489A CO 96029489 A CO96029489 A CO 96029489A CO 4520276 A1 CO4520276 A1 CO 4520276A1
- Authority
- CO
- Colombia
- Prior art keywords
- described here
- agent
- inflammatory
- percutaneous
- therapeutic anti
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
El presente invento proporciona una composiciónTerapéutica Anti-inflamatoria y analgésica, para uso tópico, que comprende:1. Nimesulide: 0,1% a 10% p/p2. Base de Vehículo que incrementa la absorción: 90 a 99,9% p/pDicha base de vehículo incrementadora percutánea actúa como un perconcentrado microportador o un microportador y comprende:1. Incrementador Percutáneo como el descrito aquí: 0,5% a 60% p/p 2. Agente activo de superficie como el descrito aquí: 0,0% a 12% p/p3. Agente gelatinizador/agente espesador como el descrito aquí: 0,2% a 19% p/p4. Uno o varios vehículos/bases incluyendo agua, como los descritos aquí: 5% a 97% p/pDe preferencia, el incrementador percutáneo/la base comprenden:1. Incrementador percutáneo como el descrito aquí: 6% a 15% p/p2. Agente activo de superficie como el descrito aquí: 0,5% a 19% p/p 3 Agente gelatinizador / agente espesador como el descrito aquí: 0,5% a 19% p/p4. Uno o varios vehículos/bases como los descritos aquí: 5% a 60% p/pPara la composición se necesita agua en una cantidad comprendida entre 1% y 15% p/p, de preferencia entre 9% y 11% p/p, y más preferiblemente entre 9,5% y 10,5% p/p.Además de los ingredientes mencionados arriba, la composición para uso tópico comprende un agente Neutralizador/agente ajustador del pH, tal como los descritos aquí, en una proporción comprendida entre 0,0% y 2,0%.The present invention provides a Therapeutic Anti-inflammatory and Analgesic composition, for topical use, comprising: 1. Nimesulide: 0.1% to 10% w / w2. Absorption Increasing Vehicle Base: 90 to 99.9% w / w Said percutaneous increasing vehicle base acts as a microcarrier or microcarrier per-concentrate and comprises: 1. Percutaneous enhancer as described here: 0.5% to 60% w / w 2. Surface active agent as described here: 0.0% to 12% w / w3. Gelatinizing agent / thickening agent as described here: 0.2% to 19% w / p4. One or more carriers / bases including water, as described herein: 5% to 97% w / w Preferably, the percutaneous enhancer / base comprises: 1. Percutaneous enhancer as described here: 6% to 15% w / w2. Surface active agent as described here: 0.5% to 19% w / w 3 Gelatinizing agent / thickening agent as described here: 0.5% to 19% w / w 4. One or more vehicles / bases as described here: 5% to 60% w / w For the composition, water is needed in an amount of between 1% and 15% w / w, preferably between 9% and 11% w / w, and more preferably between 9.5% and 10.5% w / w. In addition to the ingredients mentioned above, the composition for topical use comprises a Neutralizing agent / pH adjusting agent, such as those described herein, in a proportion comprised between 0.0% and 2.0%.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1389DE1995 | 1995-07-25 | ||
IN2047DE1995 | 1995-11-08 | ||
IN2048DE1995 IN186558B (en) | 1995-07-25 | 1995-11-08 | |
IN2046DE1995 | 1995-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4520276A1 true CO4520276A1 (en) | 1997-10-15 |
Family
ID=40929802
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO96029490A CO4520277A1 (en) | 1995-07-25 | 1996-06-06 | NEW THERAPEUTIC COMPOSITION INJECTABLE ANALGESIC CONTAINING NIMESULIDE AND MANUFACTURING PROCEDURE THEREFOR |
CO96029489A CO4520276A1 (en) | 1995-07-25 | 1996-06-06 | NEW THERAPEUTIC ANTI-INFLAMMATORY AND ANALGESICAL COMPOSITION CONTAINING NIMESULIDE, FOR TRANSDERMIC USE AND PROCEDURE OF THE SAME |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO96029490A CO4520277A1 (en) | 1995-07-25 | 1996-06-06 | NEW THERAPEUTIC COMPOSITION INJECTABLE ANALGESIC CONTAINING NIMESULIDE AND MANUFACTURING PROCEDURE THEREFOR |
Country Status (4)
Country | Link |
---|---|
CO (2) | CO4520277A1 (en) |
MY (1) | MY133741A (en) |
RS (2) | RS49716B (en) |
UA (2) | UA41974C2 (en) |
-
1996
- 1996-06-05 RS YUP-338/96A patent/RS49716B/en unknown
- 1996-06-05 RS YUP-339/96A patent/RS49717B/en unknown
- 1996-06-06 CO CO96029490A patent/CO4520277A1/en unknown
- 1996-06-06 CO CO96029489A patent/CO4520276A1/en unknown
- 1996-06-20 MY MYPI96002493A patent/MY133741A/en unknown
- 1996-07-19 UA UA96072922A patent/UA41974C2/en unknown
- 1996-07-19 UA UA96072921A patent/UA41973C2/en unknown
Also Published As
Publication number | Publication date |
---|---|
UA41974C2 (en) | 2001-10-15 |
UA41973C2 (en) | 2001-10-15 |
CO4520277A1 (en) | 1997-10-15 |
YU33896A (en) | 1999-03-04 |
MY133741A (en) | 2007-11-30 |
YU33996A (en) | 1999-03-04 |
RS49716B (en) | 2007-12-31 |
RS49717B (en) | 2007-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4323558A (en) | Topical trien containing pharmaceutical compositions and methods of use | |
AR025071A1 (en) | ADDITIVE TO IMPROVE WATER RESISTANCE OF COSMETIC OR DERMATOLOGICAL FORMULATIONS | |
MX9202328A (en) | LOCAL PHARMACEUTICAL COMPOSITION CONTAINING AN ALYLAMINE COMPOUND AS THE ACTIVE AGENT. | |
FR2454301A1 (en) | ORAL ADMINISTRATIVE COMPOSITION CONTAINING ACTIVE UREA HYDROGEN PEROXIDE | |
BR0107869A (en) | Electrogenated pharmaceutical compositions | |
DK0971705T3 (en) | Hormone replacement therapy drug formulations for topical application to the skin | |
UY24246A1 (en) | TROPIC VEHICLES CONTAINING SOLUBILIZED AND STABILIZED AZELAIC ACID | |
ES2176421T3 (en) | STABLE GELIFIED TOPICAL COMPOSITION CONTAINING AN ELECTROLYTE, AN ACTIVE AND ETHYL HYDROXYTI-CELLULOSE AGENT. | |
AR007542A1 (en) | COMPOSITION | |
BR9913589A (en) | Composition, and, cosmetic process to reduce burning or irritation induced by topical application of a composition | |
ATE370730T1 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING CHELATING/SEQUESTING AGENTS AND THEIR DERMATOLOGICAL USE | |
BR9714839A (en) | Solid gel stick antiperspirant compositions | |
MX9304564A (en) | COMBINATIONS OF MUSCLE RELAXANT-IBUPROFEN. | |
ES2137044T3 (en) | USE OF OXAZOLIDINONE DERIVATIVES AS ANTIPENETRANT AGENTS IN A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION. | |
ES2065647T3 (en) | COSMETIC USE OF A COMPOSITION THAT HAS AN ANTI-ITEM ACTIVITY. | |
ES2074030A1 (en) | Carrier compositions which are self-heating and applicable to topical treatments | |
BR9810711A (en) | Topical formulation of antipruritic spray, and, process for prevention or treatment of itching in a patient | |
DK1194109T3 (en) | Topical formulations comprising skin permeation agents and their use | |
CO4520276A1 (en) | NEW THERAPEUTIC ANTI-INFLAMMATORY AND ANALGESICAL COMPOSITION CONTAINING NIMESULIDE, FOR TRANSDERMIC USE AND PROCEDURE OF THE SAME | |
SE8101374L (en) | COMPOSITIONS CONTAINING N, N-DIETHYL-M-TOLUAMIDE | |
ES2038606T3 (en) | A COMPOSITION FOR THE EXTEMPORARY PREPARATION OF FORMULATIONS INTENDED FOR TOPICAL APPLICATIONS FOR PHARMACEUTICAL AND COSMETIC USE. | |
MX9207344A (en) | IMPROVED FORMULATIONS THAT HAVE HYDROPHOBIC IMPROVERS OF TRANSDERMIC PENETRATION AND METHOD TO PROVIDE IT. | |
AR022017A1 (en) | AN AGENT TO TREAT THE DISORDER OF THE FUNCTION OF VISUAL CELLS. THE METHOD OF TREATMENT AND THE USE OF SUCH AGENT FOR THE PRODUCTION OF A PHARMACEUTICAL COMPOSITION | |
BR0011980A (en) | Cosmetic composition; and using a composition | |
PA8496901A1 (en) | DIFFOSPHATE SALT OF A 4 "DERIVATIVE-REPLACED-9-DESOXO-9A-AZA-9A-HOMOERITHROMYCIN AND ITS PHARMACEUTICAL COMPOSITION |